Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

Extended high viremics: A substantial fraction of individuals maintain high plasma viral RNA levels after acute HIV-1 subtype C infection

AIDS, Volume 25, No. 12, Year 2011

Objective: The present study addressed two questions: what fraction of individuals maintain a sustained high HIV-1 RNA load after the acute HIV-1C infection peak and how long is a high HIV-1 RNA load maintained after acute HIV-1C infection in this subpopulation? DESIGN/Methods: Plasma HIV-1 RNA dynamics were studied in 77 participants with primary HIV-1C infection from African cohorts in Gaborone, Botswana, and Durban, South Africa. HIV-infected individuals who maintained mean viral load of at least 100000 (5.0 log10)copies/ml after 100 days postseroconversion (p/s) were termed extended high viremics. Individuals were followed longitudinally for a median [interquartile range (IQR)] of 573 (226-986) days p/s. Results: The proportion of extended high viremics was 34% [95% confidence interval (CI) 23-44%] during the period 100-300 days p/s and 19% (95% CI 9-29%) over the period of 200-400 days p/s. The median (IQR) duration of HIV-1 RNA load at least 100000copies/ml among extended high viremics was 271 (188-340) days p/s. For the subset with average viral load at least 100000copies/ml during 200-400 days p/s, the median (IQR) duration was 318 (282-459) days. The extended high viremics had a significantly shorter time to CD4+ cell decline to 350cells/μl (median: 88 vs. 691 days p/s for those not designated as extended high viremics; P<0.0001, Gehan-Wilcoxon test). Conclusion: A high proportion of extended high viremics-individuals maintaining high plasma HIV-1 RNA load after acute infection-have been identified during primary HIV-1 subtype C infection. These extended high viremics likely contribute disproportionately to HIV-1 incidence. © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Statistics
Citations: 63
Authors: 9
Affiliations: 6
Identifiers
Research Areas
Infectious Diseases
Study Design
Cohort Study
Study Locations
Botswana
South Africa